EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A proof-of-concept point-of-care test for the serodiagnosis of human amebic liver abscess

Rutchanee Rodpai, Penchom Janwan, Lakkhana Sadaow, Patcharaporn Boonroumkaew, Oranuch Sanpool, Tongjit Thanchomnang, Hiroshi Yamasaki, Toshihiro Mita, Pewpan M Intapan, Wanchai Maleewong

PeerJ · 2025

DOI: 10.7717/peerj.19181 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PeerJ, 2025. Verfasst von Rutchanee Rodpai und 9 weiteren Autor:innen. Beteiligte Einrichtung: Mekong Health Science Research Institute, Khon Kaen University, Khon Kaen, Thailand. Hauptthemen laut MEDLINE: Liver Abscess, Amebic, Point-of-Care Testing, Entamoeba histolytica, Serologic Tests. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Council of Thailand, Research Program from Research and Graduate Studies, Khon Kaen University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Amebic liver abscess (ALA), caused by an extraintestinal invasion of the virulent protozoan Entamoeba histolytica , is important among parasitic causes of morbidity and mortality, especially in the tropics. Clinical symptoms, medical-imaging abnormalities of the liver and serological tests are normally made for supportive diagnosis. Serum-based enzyme-linked immunosorbent assay (ELISA) has been conventionally used for diagnosing ALA but is time-consuming and sophisticated equipment is required. Therefore, we sought to develop a new and rapid innovative point-of-care immunochromatographic test (ICT) that can use whole blood as an alternative to serum-based ELISA. An ICT tool using simulated whole-blood samples was developed for immunoglobulin G antibody detection, and its diagnostic efficiency was evaluated in comparison with serum-based ELISA.

Methods

Both methods were tested to assess their diagnostic performance using a total of 253 serum samples. These came from ALA patients ( n = 13), healthy individuals ( n = 40), and patients with other diseases ( n = 200).

Results

Amebiasis-ICT exhibited 100% (95% confidential interval (CI) [75.3–100.0]) sensitivity and 97.1% (95% CI [94.1–98.8]) specificity, whereas ELISA gave the same sensitivity (100% 95% CI [75.3 –100.0]) and slightly lower specificity (95.8% 95% CI [92.5–98.0]). There were no significant differences in sensitivity and specificity between the two tests (Exact McNemar’s test; p > 0.05), with Cohen’s kappa agreement 96.44% ( κ -value = 0.771, p < 0.001) indicating substantial agreement.

Conclusion

This ICT tool using simulated whole-blood samples has a high possibility of being used with real whole blood. Therefore, since there is no need to separate serum, this can be considered an innovative diagnostic tool to replace serum-based ELISA in clinics and field surveys in remote areas where medical facilities are limited.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver Abscess, AmebicPoint-of-Care TestingEntamoeba histolyticaSerologic TestsChromatography, AffinityHumansEnzyme-Linked Immunosorbent AssaySensitivity and SpecificityMaleFemaleProof of Concept StudyMiddle AgedAdultImmunoglobulin GAntibodies, Protozoan

Stichwörter der Autor:innen

Amebic liver abscessEntamoeba histolyticaEnzyme-linked immunosorbent assayImmunochromatographic testPoint-of care testSerodiagnosis

Substanzen

Immunoglobulin GAntibodies, Protozoan

Autor:innen und Institutionen

  • Mekong Health Science Research Institute, Khon Kaen University, Khon Kaen, Thailand.
  • Department of Medical Technology, Faculty of Allied Health Sciences, Nakhonratchasima College, Nakhon Ratchasima, Thailand.
  • Department of Medical Technology, School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat, Thailand.
  • Department of Parasitology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
  • Faculty of Medicine, Mahasarakham University, Maha Sarakham, Thailand.
  • Department of Parasitology, National Institute of Infectious Diseases, Tokyo, Japan.

Förderung

  • National Research Council of Thailand
  • Research Program from Research and Graduate Studies, Khon Kaen University

Zitieren

APA

Rodpai, R., Janwan, P., Sadaow, L., Boonroumkaew, P., Sanpool, O., Thanchomnang, T., Yamasaki, H., Mita, T., Intapan, P. M., & Maleewong, W. (2025). A proof-of-concept point-of-care test for the serodiagnosis of human amebic liver abscess. PeerJ. https://doi.org/10.7717/peerj.19181

Vancouver

Rodpai R, Janwan P, Sadaow L, Boonroumkaew P, Sanpool O, Thanchomnang T, et al. A proof-of-concept point-of-care test for the serodiagnosis of human amebic liver abscess. PeerJ. 2025. doi:10.7717/peerj.19181

BibTeX
@article{Rodpai2025,
  author = {Rodpai, Rutchanee and Janwan, Penchom and Sadaow, Lakkhana and Boonroumkaew, Patcharaporn and Sanpool, Oranuch and Thanchomnang, Tongjit and Yamasaki, Hiroshi and Mita, Toshihiro and Intapan, Pewpan M and Maleewong, Wanchai},
  title = {A proof-of-concept point-of-care test for the serodiagnosis of human amebic liver abscess},
  journal = {PeerJ},
  year = {2025},
  doi = {10.7717/peerj.19181}
}
Kostenlos starten →